OA09809A - Mococlonal antibodies to ELAM-1 and their uses. - Google Patents
Mococlonal antibodies to ELAM-1 and their uses.Info
- Publication number
- OA09809A OA09809A OA60394A OA60394A OA09809A OA 09809 A OA09809 A OA 09809A OA 60394 A OA60394 A OA 60394A OA 60394 A OA60394 A OA 60394A OA 09809 A OA09809 A OA 09809A
- Authority
- OA
- OAPI
- Prior art keywords
- mococlonal
- elam
- antibodies
- mococlonal antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64587891A | 1991-01-24 | 1991-01-24 | |
| US73303391A | 1991-07-22 | 1991-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA09809A true OA09809A (en) | 1994-04-15 |
Family
ID=27094802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60394A OA09809A (en) | 1991-01-24 | 1993-07-22 | Mococlonal antibodies to ELAM-1 and their uses. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0568631A4 (ja) |
| JP (1) | JPH06505253A (ja) |
| AU (1) | AU1269092A (ja) |
| CA (1) | CA2100681A1 (ja) |
| IE (1) | IE920206A1 (ja) |
| IL (1) | IL100764A0 (ja) |
| NO (1) | NO932672L (ja) |
| NZ (1) | NZ241399A (ja) |
| OA (1) | OA09809A (ja) |
| SK (1) | SK77393A3 (ja) |
| WO (1) | WO1992012729A1 (ja) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646123A (en) * | 1991-06-10 | 1997-07-08 | Alberta Research Council | Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen |
| US6004555A (en) * | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
| US5877289A (en) * | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
| US6093399A (en) * | 1992-03-05 | 2000-07-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
| US6749853B1 (en) | 1992-03-05 | 2004-06-15 | Board Of Regents, The University Of Texas System | Combined methods and compositions for coagulation and tumor treatment |
| US6036955A (en) * | 1992-03-05 | 2000-03-14 | The Scripps Research Institute | Kits and methods for the specific coagulation of vasculature |
| US5660827A (en) * | 1992-03-05 | 1997-08-26 | Board Of Regents, The University Of Texas System | Antibodies that bind to endoglin |
| DK0627940T3 (da) * | 1992-03-05 | 2003-09-01 | Univ Texas | Anvendelse af immunokonjugater til diagnose og/eller terapi af vaskulariserede tumorer |
| US5965132A (en) | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
| US5643873A (en) * | 1992-05-06 | 1997-07-01 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1 |
| US5728802A (en) * | 1992-05-06 | 1998-03-17 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1) |
| US5648458A (en) * | 1992-05-06 | 1997-07-15 | Affymax Technologies N.V. | Peptides and compounds that bind to ELAM-1 |
| EP0602290B1 (en) * | 1992-12-04 | 1999-08-25 | ConjuChem, Inc. | Antibody-conjugated Hepatitis B surface antigen and use thereof |
| US5723116A (en) * | 1995-01-06 | 1998-03-03 | University Of South Florida | Decreased mortality of severe acute pancreatitis following proximal cytokine blockade |
| WO1996040942A1 (en) * | 1995-06-07 | 1996-12-19 | Cytel Corporation | Humanized antibodies to e-selectin |
| US6548663B1 (en) | 1998-03-31 | 2003-04-15 | Bristol-Myers Squibb Pharma Company | Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
| US6524553B2 (en) | 1998-03-31 | 2003-02-25 | Bristol-Myers Squibb Pharma Company | Quinolone vitronectin receptor antagonist pharmaceuticals |
| US6537520B1 (en) | 1998-03-31 | 2003-03-25 | Bristol-Myers Squibb Pharma Company | Pharmaceuticals for the imaging of angiogenic disorders |
| NZ508873A (en) | 1998-07-13 | 2003-10-31 | Univ Texas | Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| US6818213B1 (en) | 1998-07-13 | 2004-11-16 | Board Of Regents, The University Of Texas System | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
| NZ511677A (en) | 1998-12-18 | 2003-10-31 | Du Pont Pharm Co | Vitronectin receptor antagonist pharmaceuticals |
| US6511649B1 (en) | 1998-12-18 | 2003-01-28 | Thomas D. Harris | Vitronectin receptor antagonist pharmaceuticals |
| US6569402B1 (en) | 1998-12-18 | 2003-05-27 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
| US6794518B1 (en) | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
| WO2000035887A2 (en) | 1998-12-18 | 2000-06-22 | Du Pont Pharm Co | Vitronectin receptor antagonist pharmaceuticals |
| US7030219B2 (en) | 2000-04-28 | 2006-04-18 | Johns Hopkins University | B7-DC, Dendritic cell co-stimulatory molecules |
| BRPI0917891A2 (pt) * | 2008-08-25 | 2015-11-24 | Amplimmune Inc | antagonistas de pd-1 e métodos de utilização dos mesmos |
| EP3620531A4 (en) | 2017-05-02 | 2021-03-17 | National Center of Neurology and Psychiatry | METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS |
| KR102771895B1 (ko) * | 2017-10-20 | 2025-02-21 | 가꼬우호우징 효고 이카다이가쿠 | 항il-6 수용체 항체를 함유하는 수술 후의 유착을 억제하기 위한 의약 조성물 |
| JP7501876B2 (ja) | 2019-04-17 | 2024-06-18 | 国立大学法人広島大学 | Ｉｌ－６阻害剤及びｃｃｒ２阻害剤を組み合わせて投与することを特徴とする泌尿器がんの治療剤 |
| BR112022014417A2 (pt) | 2020-01-24 | 2022-09-13 | Pfizer | Anticorpos anti-e-selectina, composições e métodos de uso |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990005539A1 (en) * | 1988-11-14 | 1990-05-31 | Brigham And Women's Hospital | Antibodies specific for elam-1 and the use thereof |
| US5081034A (en) * | 1988-11-14 | 1992-01-14 | Brigham & Women's Hospital | Cloned genes which encode elam-1 |
| US5272263A (en) * | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
-
1992
- 1992-01-23 JP JP4505427A patent/JPH06505253A/ja active Pending
- 1992-01-23 SK SK773-93A patent/SK77393A3/sk unknown
- 1992-01-23 AU AU12690/92A patent/AU1269092A/en not_active Abandoned
- 1992-01-23 CA CA002100681A patent/CA2100681A1/en not_active Abandoned
- 1992-01-23 EP EP92905123A patent/EP0568631A4/en not_active Withdrawn
- 1992-01-23 WO PCT/US1992/000577 patent/WO1992012729A1/en not_active Ceased
- 1992-01-23 IE IE020692A patent/IE920206A1/en not_active Application Discontinuation
- 1992-01-24 IL IL100764A patent/IL100764A0/xx unknown
- 1992-01-24 NZ NZ241399A patent/NZ241399A/en unknown
-
1993
- 1993-07-22 OA OA60394A patent/OA09809A/en unknown
- 1993-07-23 NO NO93932672A patent/NO932672L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ241399A (en) | 1994-06-27 |
| CA2100681A1 (en) | 1992-07-25 |
| IE920206A1 (en) | 1992-07-29 |
| SK77393A3 (en) | 1994-12-07 |
| NO932672D0 (no) | 1993-07-23 |
| WO1992012729A1 (en) | 1992-08-06 |
| EP0568631A4 (en) | 1995-04-05 |
| NO932672L (no) | 1993-09-23 |
| JPH06505253A (ja) | 1994-06-16 |
| IL100764A0 (en) | 1992-09-06 |
| EP0568631A1 (en) | 1993-11-10 |
| AU1269092A (en) | 1992-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA09809A (en) | Mococlonal antibodies to ELAM-1 and their uses. | |
| IL101690A0 (en) | Antibodies and methods utilizing the same | |
| IL98764A0 (en) | Oxamides | |
| HU9200865D0 (en) | Triazinyl-substituted acrylacid esther | |
| EP0804235A4 (en) | ANTIBODIES AGAINST P-SELECTIN AND THEIR USE | |
| ZA943110B (en) | Peptides and compounds that bind to elam-1. | |
| EP0437959A3 (en) | Clip | |
| GB2255083B (en) | Improvements relating to closures | |
| EP0646014A4 (en) | USING HYPERIMMUNE MILK TO INCREASE LIFETIME. | |
| GB2240807B (en) | Clip | |
| GB2248775B (en) | Clip | |
| GB9223200D0 (en) | Improvements to electrocardiagraphs | |
| HU9503156D0 (en) | Antibodies to p-selectin and their uses | |
| GB9223676D0 (en) | Modified antibodies | |
| EP0498766A3 (en) | Modified polyarylenethers | |
| ZA92468B (en) | Monoclonal antibodies to ELAM-1 and their uses | |
| GB9115010D0 (en) | Antibody | |
| GB9103642D0 (en) | Improvements relating to swings and the like | |
| GB9121645D0 (en) | Antibodies to gelatinase | |
| GB9115498D0 (en) | Utility | |
| ZA922978B (en) | Novel antibodies and methods for their use. | |
| HU912512D0 (en) | Nonorganic based enzyme-carrier, and the enzymes bound to the carrier | |
| GB9124019D0 (en) | Improvements to signs | |
| GB9123591D0 (en) | Improvements to auto-refractors | |
| GB9124953D0 (en) | Improvements to auto-refractors |